The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Sezaby
phenobarbital sodium · PHENOBARBITAL SODIUM 100 mg/1 · Injection · Intravenous · Sun Pharmaceutical Industries, Inc.
NDC 62756-0301-01 · 1 INJECTION in 1 VIAL, SINGLE-DOSE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$133.38
Reported to Texas DSHS · 2026 annual filing · Sun Pharma
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 3 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $1,172.80 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA215910
- TE code
- —
- Approval date
- Nov 17, 2022
- Patents / exclusivity
- 2 patents, 1 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | ODE-414 | Nov 17, 2029 |
| patent | 11857683 | Apr 7, 2042 |
| patent | 12636254 | Apr 7, 2042 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of phenobarbital sodium (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | PHENOBARBITAL SODIUM 130 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Bryant Ranch Prepack | PHENOBARBITAL SODIUM 65 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| BPI Labs LLC | PHENOBARBITAL SODIUM 65 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| BPI Labs LLC | PHENOBARBITAL SODIUM 130 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Cameron Pharmaceuticals | PHENOBARBITAL SODIUM 65 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | PHENOBARBITAL SODIUM 130 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | PHENOBARBITAL SODIUM 65 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | PHENOBARBITAL SODIUM 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cameron Pharmaceuticals | PHENOBARBITAL SODIUM 130 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Sezaby — NDC 62756-0301-01," retrieved September 3, 2026, https://drugdashboards.com/drug/62756030101.
Free to cite with attribution — see how the data is put together.